Home The Active Ingredient Matrix Artemisia annua (Artemisinin)

Formulation Intelligence

Artemisia annua (Artemisinin)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Artemisia annua (Artemisinin).

Artemisinin is a sesquiterpene lactone characterized by an essential endoperoxide bridge that mediates potent antimalarial and selective antineoplastic activity through the iron-dependent generation of cytotoxic free radicals and subsequent alkylation of heme-containing proteins.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

68827

Molecular Weight

282.33 g/mol

XLogP3 (Lipophilicity)

2.8

IUPAC Name

(1R,4S,5R,8S,9R,12S,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-one

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Ferrous Gluconate for [catalyzing the cleavage of the endoperoxide bridge to accelerate reactive oxygen species production]
  • Curcumin for [potentiating apoptotic signaling pathways and overcoming multidrug resistance in neoplastic cell lines]

Biological Formulation Enhancers

  • Piperine for [inhibiting CYP3A4-mediated first-pass metabolism to increase systemic plasma concentrations]
  • Medium-Chain Triglycerides (MCT) for [improving the solubilization and lymphatic transport of this highly lipophilic molecule]

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Artemisia annua (Artemisinin) across standard consumer modalities.

💊 Standard Capsules

The poor aqueous solubility of artemisinin requires the inclusion of surfactants or lipid-based excipients within the capsule to ensure consistent dissolution and prevent erratic bioavailability.

🍬 Gummy & Pectin Formats

The thermolabile nature of the endoperoxide bridge necessitates a low-temperature pectin casting process to avoid thermal degradation of the active biomarker during the gummy manufacturing cycle.

🔬 Thin-Film Oral Strips

The relatively high therapeutic dose and hydrophobic crystalline structure of artemisinin pose significant challenges for maintaining film flexibility and achieving a homogenous dispersion within the thin-film polymer matrix.

For Brand Founders

Formulate with Artemisia annua (Artemisinin)

Ready to launch a product featuring Artemisia annua (Artemisinin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Artemisia annua (Artemisinin) Bioavailability

Need absolute proof that your Artemisia annua (Artemisinin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Artemisia annua (Artemisinin) Degradation Testing

Is your Artemisia annua (Artemisinin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation